28 July 2015 - Deborah Wilkes
Archived
Sales by Pfizer's Consumer Healthcare business in the US dropped by 6% in the second quarter of 2015, despite a "strong performance" from Nexium (esomeprazole) as it entered its second year as an OTC medicine.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.